{"id":12905,"date":"2019-03-22T09:15:50","date_gmt":"2019-03-22T13:15:50","guid":{"rendered":"https:\/\/medicarereport.org\/?p=12905"},"modified":"2019-03-22T09:15:50","modified_gmt":"2019-03-22T13:15:50","slug":"alzheimers-and-amyloid-its-time-to-do-something-else","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=12905","title":{"rendered":"Alzheimer\u2019s and amyloid: \u2018It\u2019s time to do something else\u2019"},"content":{"rendered":"<p><span class=\"big-cap\">I<\/span>f there is anything more certain than the failure of experimental Alzheimer\u2019s drugs \u2014 nearly 300, at last count \u2014 it is the immediate reaction of many diehard supporters of the amyloid hypothesis: They insist that idea, which served as the basis for most of those compounds, is still sound.\u00a0 Continue reading <a href=\"https:\/\/www.statnews.com\/2019\/03\/21\/alzheimers-amyloid-time-to-do-something-else\/?utm_campaign=KHN%3A%20First%20Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=71033369&amp;_hsenc=p2ANqtz-_-Ks7qsWnkRC0JLZwZlKqyYVp9n9JP9MpwYXkaxFZCpQseWkOjbzZVfY5nT0ZS_DbzWt9fMVIZcHK37kzQLzHyX9KGoA&amp;_hsmi=71033369\">article here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>If there is anything more certain than the failure of experimental Alzheimer\u2019s drugs \u2014 nearly 300, at last count \u2014<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,15],"tags":[],"class_list":["post-12905","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12905"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12905\/revisions"}],"predecessor-version":[{"id":12906,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/12905\/revisions\/12906"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12905"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12905"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}